CS315291A3 - 1-/3,4-dihydro-2-oxo-1h-quinolin-6-yl/-2-/4/2 -phenylethyl/piperidin-1-yl/ethanol and ethanone, process of their preparation and their application in therapy - Google Patents

1-/3,4-dihydro-2-oxo-1h-quinolin-6-yl/-2-/4/2 -phenylethyl/piperidin-1-yl/ethanol and ethanone, process of their preparation and their application in therapy

Info

Publication number
CS315291A3
CS315291A3 CS913152A CS315291A CS315291A3 CS 315291 A3 CS315291 A3 CS 315291A3 CS 913152 A CS913152 A CS 913152A CS 315291 A CS315291 A CS 315291A CS 315291 A3 CS315291 A3 CS 315291A3
Authority
CS
Czechoslovakia
Prior art keywords
ethanone
quinolin
piperidin
phenylethyl
dihydro
Prior art date
Application number
CS913152A
Other languages
Czech (cs)
English (en)
Inventor
Jonathan Frost
Patrick Lardenois
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of CS315291A3 publication Critical patent/CS315291A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS913152A 1990-10-18 1991-10-17 1-/3,4-dihydro-2-oxo-1h-quinolin-6-yl/-2-/4/2 -phenylethyl/piperidin-1-yl/ethanol and ethanone, process of their preparation and their application in therapy CS315291A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9012872A FR2668149B1 (fr) 1990-10-18 1990-10-18 Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Publications (1)

Publication Number Publication Date
CS315291A3 true CS315291A3 (en) 1992-05-13

Family

ID=9401336

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913152A CS315291A3 (en) 1990-10-18 1991-10-17 1-/3,4-dihydro-2-oxo-1h-quinolin-6-yl/-2-/4/2 -phenylethyl/piperidin-1-yl/ethanol and ethanone, process of their preparation and their application in therapy

Country Status (18)

Country Link
US (1) US5212181A (pt)
EP (1) EP0481853A1 (pt)
JP (1) JPH04257579A (pt)
KR (1) KR920008029A (pt)
AU (1) AU638173B2 (pt)
CA (1) CA2052760A1 (pt)
CS (1) CS315291A3 (pt)
FI (1) FI914906A7 (pt)
FR (1) FR2668149B1 (pt)
HU (1) HUT59391A (pt)
IE (1) IE913653A1 (pt)
IL (1) IL99779A0 (pt)
MX (1) MX9101604A (pt)
NO (1) NO914071L (pt)
NZ (1) NZ240261A (pt)
PL (1) PL292089A1 (pt)
PT (1) PT99247A (pt)
ZA (1) ZA918293B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524846A1 (fr) * 1991-06-27 1993-01-27 Synthelabo Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
US6255322B1 (en) * 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
FR2699534B1 (fr) * 1992-12-21 1995-02-03 Synthelabo Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
US5998624A (en) * 1997-05-07 1999-12-07 Emory University Haloisoquinoline carboxamide
JPWO2004011430A1 (ja) * 2002-07-25 2005-11-24 アステラス製薬株式会社 ナトリウムチャネル阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NZ240261A (en) 1993-01-27
JPH04257579A (ja) 1992-09-11
FI914906L (fi) 1992-04-19
IL99779A0 (en) 1992-08-18
PT99247A (pt) 1992-08-31
KR920008029A (ko) 1992-05-27
AU8589291A (en) 1992-04-30
IE913653A1 (en) 1992-04-22
HUT59391A (en) 1992-05-28
CA2052760A1 (en) 1992-04-19
AU638173B2 (en) 1993-06-17
MX9101604A (es) 1992-06-05
HU913267D0 (en) 1992-01-28
US5212181A (en) 1993-05-18
FI914906A7 (fi) 1992-04-19
NO914071D0 (no) 1991-10-17
FR2668149A1 (fr) 1992-04-24
EP0481853A1 (fr) 1992-04-22
ZA918293B (en) 1992-07-29
FR2668149B1 (fr) 1994-09-23
NO914071L (no) 1992-04-21
PL292089A1 (en) 1992-06-26
FI914906A0 (fi) 1991-10-17

Similar Documents

Publication Publication Date Title
EG19752A (en) Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use
IL88182A0 (en) Derivatives of 1-desoxynojirimicyin and 1-desoxymannonojirimycin,their preparation and their use in medicaments
CS225991A3 (en) Substituted azoles, process of their preparation and their use
IL99612A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
CS246191A3 (en) Corticoid-17-alkylcarbonates, being substituted in position 17, process of their preparation and medicaments comprising them
IL89880A0 (en) 9alpha-hydroxy-17-methylene steroids,their preparation and their use in the synthesis of corticosteroids
EP0457155A3 (en) Carboxylate-ether derivatives of alkylmono- and alkylpolyglucosides, process for their preparation and their use
ZA885150B (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
CS315291A3 (en) 1-/3,4-dihydro-2-oxo-1h-quinolin-6-yl/-2-/4/2 -phenylethyl/piperidin-1-yl/ethanol and ethanone, process of their preparation and their application in therapy
IL117455A0 (en) Piperidine derivatives process for the preparation thereof and application thereof in therapeutics
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
GB2223225B (en) Neutrophil-activating factor: its production and use in treatment
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
AP9300575A0 (en) Piperidine derivatives their preparation and their application in therapy
IL108343A0 (en) 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
ZA911927B (en) Labdanes and process for their preparation
ZA904290B (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives,their preparation and their application in therapy
IL96127A0 (en) Triazole derivatives and process for their preparation
EP0520290A3 (en) Ethers of 1-hydroxy-hex-5-en-2-on, process for their preparation and their use in perfumery
NZ240150A (en) Fermentation medium and its use in the production of ivermectin derivatives
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety